<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6676772</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31402852</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6676772</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fnins.2019.00775</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Main findings of functional connectivity analyses using PET and fMRI.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>TABLE 1</label><caption><p>Main findings of functional connectivity analyses using PET and fMRI.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Authors (year)</bold></td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Participants</bold></td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Method of analysis and main findings</bold></td></tr></thead><tbody><tr><td valign="top" align="justify" rowspan="1" colspan="1"><xref rid="B17" ref-type="bibr">Savio et al., 2017</xref></td><td valign="top" align="justify" rowspan="1" colspan="1">A total of 22 healthy, right-handed participants (15 men, 7 women; mean age: 54.5 ± 10.0 years)</td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Acquisition:</bold> Simultaneous PET/MRI with static <sup>18</sup>F-FDG-PET. <bold>Analysis:</bold> ICA (20 components). <bold>Results:</bold> Similar RSNs were detected via fMRI and <sup>18</sup>F-FDG PET when resting-state fMRI and <sup>18</sup>F-FDG-PET data were acquired simultaneously.</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"><xref rid="B11" ref-type="bibr">Marchitelli et al., 2018</xref></td><td valign="top" align="justify" rowspan="1" colspan="1">A total of 23 patients with aMCI/AD and 23 healthy older adults</td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Acquisition:</bold> Simultaneous PET/MRI with static <sup>18</sup>F-FDG-PET. <bold>Analysis:</bold> Uptake on <sup>18</sup>F-FDG-PET and resting-state fMRI metrics were compared between patients with aMCI/AD and controls and expressed as <italic>Z</italic> scores. <bold>Results:</bold> For within-subject PET/fMRI comparisons, correlations were high overall in healthy controls but 17% lower in patients with aMCI/AD (significant at <italic>p</italic> &lt; 0.05). For between-subject comparisons, FDG/gICA-DR exhibited the greatest overlap around the posterior DMN nodes.</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"><xref rid="B25" ref-type="bibr">Yokoi et al., 2018</xref></td><td valign="top" align="justify" rowspan="1" colspan="1">Amyloid-positive patients with early AD (<italic>n</italic> = 23) and amyloid-negative control participants (<italic>n</italic> = 24)</td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Acquisition:</bold> Separate PET (<sup>18</sup>F-THK5351, static) and MRI (3T). <bold>Analysis:</bold> Seed-based connectivity analysis was performed by generating seed ROIs based on regions exhibiting the most significant differences in <sup>18</sup>F-THK5351 retention between patients with AD and controls. <bold>Results:</bold> Patients with AD exhibited significant decreases in connectivity between the PCC and widespread brain regions.</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"><xref rid="B10" ref-type="bibr">Kim et al., 2019</xref></td><td valign="top" align="justify" rowspan="1" colspan="1">A total of 16 patients with MDD without comorbidities and 15 healthy controls</td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Acquisition:</bold> Separate PET [(<sup>11</sup>C)ABP688, dynamic] and MRI (3T). <bold>Analysis:</bold> The BP<sub>ND</sub> of [<sup>11</sup>C]ABP688 was quantified using the SRTM for mGluR5 availability. Seed-based functional connectivity analysis was performed using resting-state fMRI data with regions derived from quantitative [<sup>11</sup>C]ABP688 PET as seeds. <bold>Results:</bold> Patterns of correlation between [<sup>11</sup>C]ABP688 BP<sub>ND</sub> and the strength of functional connectivity involving the superior prefrontal cortex were opposite in the depression and control groups.</td></tr><tr><td valign="top" align="justify" rowspan="1" colspan="1"><xref rid="B7" ref-type="bibr">Hamilton et al., 2018</xref></td><td valign="top" align="justify" rowspan="1" colspan="1">A total of 16 patients with MDD and 14 controls</td><td valign="top" align="justify" rowspan="1" colspan="1"><bold>Acquisition:</bold> Simultaneous fMRI and <sup>11</sup>C-raclopride PET targeting the dopamine D<sub>2</sub> receptor. <bold>Analysis:</bold> BP<sub>ND</sub> was estimated via the MRTM, using the cerebellum as the reference tissue. Functional connectivity analysis was performed using striatal regions exhibiting significant between-group BP<sub>ND</sub> differences as seeds. <bold>Results:</bold> Increased BP<sub>ND</sub> and decreased connectivity were observed in the striatum. The BP<sub>ND</sub> was increased in both the left ventral striatum and right dorsal striatum in patients with MDD. Connectivity between these regions and cortical targets was also decreased in the MDD group.</td></tr></tbody></table><table-wrap-foot><attrib><italic>ICA, independent component analysis; aMCI/AD, amnestic mild cognitive impairment/mild-to-moderate Alzheimer’s disease; gICA- DR, group independent component analysis with dual regression; PCC, posterior cingulate cortex; BP<sub><italic>ND</italic></sub>, non-displaceable binding potential; SRTM, simplified reference tissue model; mGluR5, metabotropic glutamate receptor-5; MRTM, multi-linear reference tissue model; MDD, major depressive disorder.</italic></attrib></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Main findings of functional connectivity analyses using PET and fMRI.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="justify">Authors (year)</td><td valign="top" align="justify">Participants</td><td valign="top" align="justify">Method of analysis and main findings</td></tr></thead><tbody><tr><td valign="top" align="justify">???</td><td valign="top" align="justify">A total of 22 healthy, right-handed participants (15 men, 7 women; mean age: 54.5 ± 10.0 years)</td><td valign="top" align="justify">Acquisition: Simultaneous PET/MRI with static 18F-FDG-PET. Analysis: ICA (20 components). Results: Similar RSNs were detected via fMRI and 18F-FDG PET when resting-state fMRI and 18F-FDG-PET data were acquired simultaneously.</td></tr><tr><td valign="top" align="justify">???</td><td valign="top" align="justify">A total of 23 patients with aMCI/AD and 23 healthy older adults</td><td valign="top" align="justify">Acquisition: Simultaneous PET/MRI with static 18F-FDG-PET. Analysis: Uptake on 18F-FDG-PET and resting-state fMRI metrics were compared between patients with aMCI/AD and controls and expressed as Z scores. Results: For within-subject PET/fMRI comparisons, correlations were high overall in healthy controls but 17% lower in patients with aMCI/AD (significant at p &lt; 0.05). For between-subject comparisons, FDG/gICA-DR exhibited the greatest overlap around the posterior DMN nodes.</td></tr><tr><td valign="top" align="justify">???</td><td valign="top" align="justify">Amyloid-positive patients with early AD (n = 23) and amyloid-negative control participants (n = 24)</td><td valign="top" align="justify">Acquisition: Separate PET (18F-THK5351, static) and MRI (3T). Analysis: Seed-based connectivity analysis was performed by generating seed ROIs based on regions exhibiting the most significant differences in 18F-THK5351 retention between patients with AD and controls. Results: Patients with AD exhibited significant decreases in connectivity between the PCC and widespread brain regions.</td></tr><tr><td valign="top" align="justify">???</td><td valign="top" align="justify">A total of 16 patients with MDD without comorbidities and 15 healthy controls</td><td valign="top" align="justify">Acquisition: Separate PET [(11C)ABP688, dynamic] and MRI (3T). Analysis: The BPND of [11C]ABP688 was quantified using the SRTM for mGluR5 availability. Seed-based functional connectivity analysis was performed using resting-state fMRI data with regions derived from quantitative [11C]ABP688 PET as seeds. Results: Patterns of correlation between [11C]ABP688 BPND and the strength of functional connectivity involving the superior prefrontal cortex were opposite in the depression and control groups.</td></tr><tr><td valign="top" align="justify">???</td><td valign="top" align="justify">A total of 16 patients with MDD and 14 controls</td><td valign="top" align="justify">Acquisition: Simultaneous fMRI and 11C-raclopride PET targeting the dopamine D2 receptor. Analysis: BPND was estimated via the MRTM, using the cerebellum as the reference tissue. Functional connectivity analysis was performed using striatal regions exhibiting significant between-group BPND differences as seeds. Results: Increased BPND and decreased connectivity were observed in the striatum. The BPND was increased in both the left ventral striatum and right dorsal striatum in patients with MDD. Connectivity between these regions and cortical targets was also decreased in the MDD group.</td></tr></tbody></table></div>ICA, independent component analysis; aMCI/AD, amnestic mild cognitive impairment/mild-to-moderate Alzheimer’s disease; gICA- DR, group independent component analysis with dual regression; PCC, posterior cingulate cortex; BPND, non-displaceable binding potential; SRTM, simplified reference tissue model; mGluR5, metabotropic glutamate receptor-5; MRTM, multi-linear reference tissue model; MDD, major depressive disorder.</transformed-table></extracted-table></extracted-tables-set>